NCT04726839View on ClinicalTrials.gov

Biomarkers algOrithm for strOke diagnoSis and Treatment Resistance Prediction

CompletedOBSERVATIONAL
Enrollment

3,880

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

July 10, 2025

Study Completion Date

July 10, 2025

Conditions
Stroke, IschemicLarge Vessel Occlusion
Interventions
OTHER

Standard of care for stroke management and evaluation of functionnal outcome at 3 months

Additional tubes at inclusion (maximum 13 mL) Collection of the mRS data during a routine visit if planned at 3 months +/-15 days or, if not during a specific research phone call at 3 months

Trial Locations (4)

75010

Lariboisière, Paris

Unknown

Department Neurology Caen Hospital, Caen

Rothschild Foundation Hospital, Paris

Hospital Foch, Suresnes

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04726839 - Biomarkers algOrithm for strOke diagnoSis and Treatment Resistance Prediction | Biotech Hunter | Biotech Hunter